{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:51:01Z","timestamp":1780933861915,"version":"3.54.1"},"reference-count":159,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.ccm.2009.08.012","type":"journal-article","created":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T14:08:56Z","timestamp":1258553336000},"page":"827-846","source":"Crossref","is-referenced-by-count":45,"title":["Screening and Preventive Therapy for Tuberculosis"],"prefix":"10.1016","volume":"30","author":[{"given":"Ben J.","family":"Marais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Ayles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Godfrey-Faussett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccm.2009.08.012_bib1","series-title":"Global tuberculosis control. Epidemiology, strategy, financing","author":"WHO Report","year":"2009"},{"key":"10.1016\/j.ccm.2009.08.012_bib2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/518660","article-title":"Tuberculosis and HIV infection: the global setting","volume":"196","author":"Nunn","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib3","author":"Centres for disease Control and Prevention"},{"key":"10.1016\/j.ccm.2009.08.012_bib4","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM199910143411602","article-title":"Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment","volume":"341","author":"Van Rie","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccm.2009.08.012_bib5","first-page":"942","article-title":"Contribution of reinfection to recurrent tuberculosis in South African gold miners","volume":"12","author":"Charalambous","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib6","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1164\/rccm.200409-1200OC","article-title":"Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis","volume":"171","author":"Verver","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2009.08.012_bib7","first-page":"935","article-title":"A controlled trial of community-wide isoniazid prophylaxis in Alaska","volume":"95","author":"Comstock","year":"1967","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib8","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1183\/09031936.00120908","article-title":"LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement","volume":"33","author":"Mack","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2009.08.012_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s15010-009-8450-7","article-title":"Lazy, dynamic or minimally recrudescent? On the elusive nature and location of the mycobacterium responsible for latent tuberculosis","volume":"37","author":"Ehlers","year":"2009","journal-title":"Infection"},{"key":"10.1016\/j.ccm.2009.08.012_bib10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1473-3099(08)70182-8","article-title":"Paediatric tuberculosis","volume":"8","author":"Newton","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib11","first-page":"259","article-title":"The burden of childhood tuberculosis and the accuracy of routine surveillance data in a high-burden setting","volume":"10","author":"Marais","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib12","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(02)11082-8","article-title":"Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study","volume":"360","author":"Chintu","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2009.08.012_bib13","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/501018","article-title":"Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions","volume":"42","author":"Lawn","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib14","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1086\/518659","article-title":"Diagnosis and management challenges of childhood TB in the era of HIV","volume":"196","author":"Marais","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib15","first-page":"225","article-title":"Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting","volume":"12","author":"Cotton","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib16","first-page":"90","article-title":"Contacts of cases of active pulmonary tuberculosis","volume":"50","author":"Grzybowski","year":"1975","journal-title":"Bull Int Union Tuberc"},{"key":"10.1016\/j.ccm.2009.08.012_bib17","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1164\/ajrccm.162.6.2004022","article-title":"Outcomes of contact investigations of infectious tuberculosis patients","volume":"162","author":"Marks","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2009.08.012_bib18","first-page":"843","article-title":"Risk factors for transmission of Mycobacterium tuberculosis from HIV-infected tuberculosis patients, Botswana","volume":"6","author":"Kenyon","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib19","doi-asserted-by":"crossref","first-page":"e608","DOI":"10.1542\/peds.111.5.e608","article-title":"Risk factors for tuberculosis infection in children in contact with infectious tuberculosis cases in The Gambia, West Africa","volume":"111","author":"Lienhardt","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ccm.2009.08.012_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1179\/146532806X120291","article-title":"Risk factors for TB infection and disease in young childhood contacts in Malawi","volume":"26","author":"Sinfield","year":"2006","journal-title":"Ann Trop Paediatr"},{"key":"10.1016\/j.ccm.2009.08.012_bib21","first-page":"1305","article-title":"The burden of childhood tuberculosis: a public health perspective","volume":"9","author":"Marais","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib22","first-page":"346","article-title":"Trend in the prevalence of TB infection and ARTI after implementation of a DOTS programme in south India","volume":"10","author":"Gopi","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib23","first-page":"718","article-title":"Risk of infection with Mycobacterium tuberculosis in Malawi: national tuberculin survey 1994","volume":"8","author":"Salaniponi","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib24","first-page":"255","article-title":"Annual risk of tuberculosis infection in West Sumatra Province, Indonesia","volume":"12","author":"Bachtiar","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1086\/589750","article-title":"Rates of tuberculosis transmission to children and adolescents in a community with a high prevalence of HIV infection among adults","volume":"47","author":"Middelkoop","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-3156.2008.02213.x","article-title":"No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa","volume":"14","author":"Kritzinger","year":"2009","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ccm.2009.08.012_bib27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1128\/JCM.02490-08","article-title":"Mycobacterium tuberculosis transmission is not related to household genotype in a setting of high endemicity","volume":"47","author":"Marais","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ccm.2009.08.012_bib28","first-page":"426","article-title":"Adult-to-child transmission of tuberculosis: household or community contact?","volume":"7","author":"Schaaf","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0140-6736(03)15332-9","article-title":"Proportion of tuberculosis transmission that takes place in households in a high-incidence area","volume":"363","author":"Verver","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2009.08.012_bib30","first-page":"879","article-title":"Identification and management of latent tuberculosis infection","volume":"79","author":"Hauck","year":"2009","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ccm.2009.08.012_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1473-3099(04)00939-9","article-title":"Perinatal tuberculosis and HIV-1: considerations for resource-limited settings","volume":"4","author":"Pillay","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/08035250600636560","article-title":"Nosocomial transmission of Mycobacterium tuberculosis in kangaroo mother care units: a risk in tuberculosis-endemic areas","volume":"95","author":"Heyns","year":"2006","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.ccm.2009.08.012_bib33","first-page":"392","article-title":"The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era","volume":"8","author":"Marais","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib34","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2009.08.012_bib35","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1164\/rccm.200511-1809SO","article-title":"Childhood pulmonary tuberculosis \u2013 old wisdom and new challenges","volume":"173","author":"Marais","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2009.08.012_bib36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1086\/595012","article-title":"High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies","volume":"48","author":"Hesseling","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1086\/313925","article-title":"Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children","volume":"31","author":"Madhi","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib38","first-page":"424","article-title":"Childhood tuberculosis in Malawi: nationwide case-finding and treatment outcomes","volume":"6","author":"Harries","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib39","series-title":"Guidance for national tuberculosis programmes on the management of tuberculosis in children. Stop TB Partnership Childhood TB Subgroup","author":"World Health Organization","year":"2006"},{"key":"10.1016\/j.ccm.2009.08.012_bib40","series-title":"Interventions for tuberculosis control and elimination","author":"Rieder","year":"2002"},{"issue":"RR-15","key":"10.1016\/j.ccm.2009.08.012_bib41","first-page":"16","article-title":"Guidelines for the investigation of contacts of persons with infectious tuberculosis","volume":"54","author":"Centers for Disease Control and Prevention","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ccm.2009.08.012_bib42","first-page":"585","article-title":"Poor attendance at a child TB contact clinic in Malawi","volume":"10","author":"Nyirenda","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib43","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00247-004-1238-0","article-title":"A proposed radiological classification of childhood intra-thoracic tuberculosis","volume":"33","author":"Marais","year":"2004","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.ccm.2009.08.012_bib44","first-page":"942","article-title":"Prophylactic effects of isoniazid on primary tuberculosis in children","volume":"76","year":"1957","journal-title":"Am Rev Tuberc"},{"key":"10.1016\/j.ccm.2009.08.012_bib45","doi-asserted-by":"crossref","first-page":"e1646","DOI":"10.1542\/peds.2007-3138","article-title":"Symptom-based screening of child tuberculosis contacts: improved feasibility in resource-limited settings","volume":"121","author":"Kruk","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ccm.2009.08.012_bib46","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/QAD.0b013e32832956ad","article-title":"Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay","volume":"23","author":"Davies","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2009.08.012_bib47","article-title":"Highly discordant T-cell responses in individuals with recent household tuberculosis exposure","author":"Hesseling","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2009.08.012_bib48","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.prrv.2007.04.002","article-title":"New approaches and emerging technologies in the diagnosis of childhood tuberculosis","volume":"8","author":"Marais","year":"2007","journal-title":"Paediatr Respir Rev"},{"issue":"2","key":"10.1016\/j.ccm.2009.08.012_bib49","article-title":"Isoniazid for preventing tuberculosis in non-HIV infected persons","author":"Smieja","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ccm.2009.08.012_bib50","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jama.1974.03230430020019","article-title":"Isoniazid in the prevention and treatment of tuberculosis. A 20-year study of the effectiveness in children","volume":"229","author":"Hsu","year":"1974","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2009.08.012_bib51","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1001\/jama.1984.03340340023018","article-title":"Thirty years after isoniazid: its impact on tuberculosis in children and adolescents","volume":"251","author":"Hsu","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2009.08.012_bib52","first-page":"362","article-title":"Screening childhood contacts of patients with smear-positive pulmonary tuberculosis in Malawi","volume":"6","author":"Claessens","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib53","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jama.287.8.991","article-title":"Evaluation of investigations conducted to detect and prevent transmission of tuberculosis","volume":"287","author":"Reichler","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2009.08.012_bib54","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/bmj.39000.486400.55","article-title":"Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial","volume":"334","author":"Zar","year":"2007","journal-title":"Br Med J"},{"key":"10.1016\/j.ccm.2009.08.012_bib55","first-page":"796","article-title":"Role of individual drugs in the chemotherapy of tuberculosis","volume":"4","author":"Mitchison","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib56","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.prrv.2007.04.001","article-title":"Old and new drugs for the treatment of tuberculosis in children","volume":"8","author":"Donald","year":"2007","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.ccm.2009.08.012_bib57","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1086\/520983","article-title":"The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study","volume":"45","author":"Spyridis","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib58","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1086\/427802","article-title":"Short course therapy with rifampicin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis: a meta-analysis","volume":"40","author":"Ena","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib59","first-page":"1080","article-title":"Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis","volume":"10","author":"Gao","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib60","first-page":"96","article-title":"Tuberculosis preventive therapy in HIV-infected individuals. A joint statement of the International Union Against Tuberculosis and Lung Disease (IUATLD) and the Global Programme on AIDS and the Tuberculosis Programme of the World Health Organization (WHO)","volume":"75","year":"1994","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib61","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1067\/mjd.2003.424","article-title":"Suggested guidelines for screening and management of tuberculosis in patients taking oral glucocorticoids \u2013 an important but often neglected issue","volume":"49","author":"Chan","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 4","key":"10.1016\/j.ccm.2009.08.012_bib62","first-page":"S39","article-title":"European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.7.2. Late infections. Tuberculosis","volume":"17","author":"European Best Practice Guidelines for Renal Transplantation","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"RR-9","key":"10.1016\/j.ccm.2009.08.012_bib63","first-page":"1","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"RR-15","key":"10.1016\/j.ccm.2009.08.012_bib64","first-page":"1","article-title":"Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC","volume":"54","author":"National Tuberculosis Controllers Association","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"54","key":"10.1016\/j.ccm.2009.08.012_bib65","first-page":"1","article-title":"Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings. 2005","author":"Jensen","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"RR-16","key":"10.1016\/j.ccm.2009.08.012_bib66","first-page":"1","article-title":"Report of the Working Group on Tuberculosis among Foreign-Born Persons. Centers for Disease Control and Prevention","volume":"47","author":"Recommendations for prevention and control of tuberculosis among foreign-born persons","year":"1998","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ccm.2009.08.012_bib67","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/QAD.0b013e3283097cfa","article-title":"Effects of duration of HIV infection and secondary tuberculosis transmission on tuberculosis incidence in the South African gold mines","volume":"22","author":"Glynn","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2009.08.012_bib68","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1086\/522986","article-title":"Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries","volume":"45","author":"Brinkhof","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib69","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","article-title":"Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control","volume":"20","author":"Lawn","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2009.08.012_bib70","article-title":"Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in SA","author":"Lawn","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2009.08.012_bib71","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijantimicag.2007.07.010","article-title":"Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence","volume":"30","author":"Falagas","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ccm.2009.08.012_bib72","doi-asserted-by":"crossref","first-page":"e494","DOI":"10.1371\/journal.pmed.0030494","article-title":"Tuberculosis among health-care workers in low- and middle-income countries: a systematic review","volume":"3","author":"Joshi","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.ccm.2009.08.012_bib73","first-page":"593","article-title":"Risk of tuberculosis infection and disease associated with work in health care settings","volume":"11","author":"Menzies","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib74","first-page":"306","article-title":"Olaf Scheel, Johannes Heimbeck: their contribution to understanding the pathogenesis and prevention of tuberculosis","volume":"7","author":"Bjartveit","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.ccm.2009.08.012_bib75","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","author":"Woldehanna","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ccm.2009.08.012_bib76","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0140-6736(93)91817-6","article-title":"Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection","volume":"342","author":"Pape","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2009.08.012_bib77","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00002030-199707000-00006","article-title":"Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial","volume":"11","author":"Hawken","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2009.08.012_bib78","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199709183371201","article-title":"A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration","volume":"337","author":"Whalen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccm.2009.08.012_bib79","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJM199707313370505","article-title":"A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS","volume":"337","author":"Gordin","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccm.2009.08.012_bib80","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/00002030-199818000-00014","article-title":"Twice weekly tuberculosis preventive therapy in HIV infection in Zambia","volume":"12","author":"Mwinga","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2009.08.012_bib81","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(97)06532-X","article-title":"Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection","volume":"351","author":"Halsey","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2009.08.012_bib82","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.283.11.1445","volume":"283","author":"Gordin","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2009.08.012_bib83","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00042560-200111010-00018","article-title":"No effect of isoniazid prophylaxis for purified protein derivative-negative HIV-infected adults living in a country with endemic tuberculosis: results of a randomized trial","volume":"28","author":"Fitzgerald","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ccm.2009.08.012_bib84","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0213-005X(03)72942-5","volume":"21","author":"Rivero","year":"2003","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ccm.2009.08.012_bib85","first-page":"1114","article-title":"Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease","volume":"11","author":"Mohammed","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib86","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1086\/317485","article-title":"Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis","volume":"31","author":"Fitzgerald","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib87","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00002030-200101260-00011","article-title":"Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults","volume":"15","author":"Quigley","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2009.08.012_bib88","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00002030-200111090-00009","article-title":"Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults","volume":"15","author":"Johnson","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2009.08.012_bib89","unstructured":"Martinson N, Barnes G, Msandiwa R, et\u00a0al. Novel regimens for treating latent TB in HIV-infected adults in South Africa: a randomized clinical trial. In: 16th Conference on Retroviruses and Opportunistic Infections. 2009: Montreal."},{"key":"10.1016\/j.ccm.2009.08.012_bib90","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/ard.61.3.251","article-title":"Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long term steroid treatment","volume":"61","author":"Gaitonde","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib91","first-page":"81","article-title":"Tuberculosis prophylaxis in patients with steroid treatment and systemic rheumatic diseases. A case-control study","volume":"17","author":"Hernandez-Cruz","year":"1999","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.ccm.2009.08.012_bib92","first-page":"609","article-title":"Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy","volume":"32","author":"Mok","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ccm.2009.08.012_bib93","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2169\/internalmedicine.41.1103","article-title":"Clinical analysis of pulmonary tuberculosis in association with corticosteroid therapy","volume":"41","author":"Kobashi","year":"2002","journal-title":"Intern Med"},{"key":"10.1016\/j.ccm.2009.08.012_bib94","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.transproceed.2006.06.010","article-title":"Efficacy of isoniazid prophylaxis in renal allograft recipients","volume":"38","author":"Naqvi","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ccm.2009.08.012_bib95","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis","volume":"60","year":"1982","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ccm.2009.08.012_bib96","first-page":"827","article-title":"Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies","volume":"119","author":"Comstock","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib97","first-page":"490","article-title":"Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts","volume":"85","author":"Ferebee","year":"1962","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib98","first-page":"540","article-title":"Is cough alone adequate to screen HIV-positive persons for tuberculosis preventive therapy in developing countries?","volume":"3","author":"Hawken","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib99","first-page":"523","article-title":"Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa","volume":"10","author":"Day","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib100","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1086\/518662","article-title":"Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities","volume":"196","author":"Churchyard","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib101","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(03)14745-9","article-title":"Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana","volume":"362","author":"Mosimaneotsile","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2009.08.012_bib102","doi-asserted-by":"crossref","first-page":"e5602","DOI":"10.1371\/journal.pone.0005602","article-title":"Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities \u2013 implications for tuberculosis control in the era of HIV","volume":"4","author":"Ayles","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ccm.2009.08.012_bib103","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccm.2009.08.012_bib104","first-page":"326","article-title":"Operational assessment of isoniazid prophylaxis in a community AIDS service organisation in Uganda","volume":"6","author":"Lugada","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib105","first-page":"1037","article-title":"Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania","volume":"12","author":"Munseri","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib106","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2334-6-97","article-title":"Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa","volume":"6","author":"Szakacs","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib107","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/archinte.160.5.697","article-title":"Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial","volume":"160","author":"Tulsky","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccm.2009.08.012_bib108","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2458-6-66","article-title":"The impact of smoking on adherence to treatment for latent tuberculosis infection","volume":"6","author":"Lavigne","year":"2006","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ccm.2009.08.012_bib109","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00002030-199701000-00016","article-title":"Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai, Thailand","volume":"11","author":"Ngamvithayapong","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2009.08.012_bib110","first-page":"83","article-title":"Can the poor adhere? Incentives for adherence to TB prevention in homeless adults","volume":"8","author":"Tulsky","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib111","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1378\/chest.130.6.1712","article-title":"Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin","volume":"130","author":"Lardizabal","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2009.08.012_bib112","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/pmed.2000.0654","article-title":"No evidence for multiple-drug prophylaxis for tuberculosis compared with isoniazid alone in Southeast Asian refugees and migrants: completion and compliance are major determinants of effectiveness","volume":"30","author":"MacIntyre","year":"2000","journal-title":"Prev Med"},{"key":"10.1016\/j.ccm.2009.08.012_bib113","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1378\/chest.98.2.314","article-title":"Testing for isoniazid. An evaluation of the Arkansas method","volume":"98","author":"Schraufnagel","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2009.08.012_bib114","first-page":"576","article-title":"An incentive in tuberculosis preventive therapy for an inner city population","volume":"1","author":"Mangura","year":"1997","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib115","first-page":"1178","article-title":"Physician attitudes regarding latent tuberculosis infection: international vs. U.S. medical graduates","volume":"10","author":"Hirsch-Moverman","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib116","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/adc.2006.097220","article-title":"Adherence to isoniazid preventive chemotherapy in children: a prospective community-based study","volume":"91","author":"Marais","year":"2006","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ccm.2009.08.012_bib117","first-page":"13","article-title":"Adherence to anti-tuberculosis chemoprophylaxis and treatment in children","volume":"10","author":"van Zyl","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib118","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1086\/505398","article-title":"Safety and completion rate of short-course therapy for treatment of latent tuberculosis infection","volume":"43","author":"Cook","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib119","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1086\/444463","article-title":"National survey to measure rates of liver injury, hospitalization, and death associated with rifampin and pyrazinamide for latent tuberculosis infection","volume":"41","author":"McElroy","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"31","key":"10.1016\/j.ccm.2009.08.012_bib120","first-page":"735","article-title":"Update: adverse event data and revised American Thoracic Society\/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection\u2013United States, 2003","volume":"52","author":"Centers for Disease Control and Prevention (CDC)","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ccm.2009.08.012_bib121","unstructured":"Frydenberg A, Graham SM. A review of toxicity of first-line drugs for treatment of tuberculosis in children. Trop Med Int Health, in press."},{"key":"10.1016\/j.ccm.2009.08.012_bib122","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/598192","article-title":"Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines","volume":"48","author":"McIlleron","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib123","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1741-7015-7-19","article-title":"Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis","volume":"7","author":"Schaaf","year":"2009","journal-title":"BMC Med"},{"key":"10.1016\/j.ccm.2009.08.012_bib124","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/AAC.50.2.407-413.2006","article-title":"Low levels of pyrazinamide and ethambutol in children with tuberculosis and impact of age, nutritional status, and human immunodeficiency virus infection","volume":"50","author":"Graham","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ccm.2009.08.012_bib125","doi-asserted-by":"crossref","first-page":"e1732","DOI":"10.1542\/peds.2007-2773","article-title":"Unintended consequences: mandatory tuberculin skin testing and severe isoniazid hepatotoxicity","volume":"121","author":"Lobato","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ccm.2009.08.012_bib126","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/01.tp.0000269104.22502.d2","article-title":"Isoniazid-related hepatic failure in children: a survey of liver transplantation centers","volume":"84","author":"Wu","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.ccm.2009.08.012_bib127","first-page":"1039","article-title":"Isoniazid preventive therapy: retrospect and prospect","volume":"121","author":"Dash","year":"1980","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib128","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00006454-198909000-00019","article-title":"Incidence of hepatotoxicity in children receiving isoniazid chemoprophylaxis","volume":"8","author":"Nakajo","year":"1989","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ccm.2009.08.012_bib129","first-page":"144","article-title":"Hepatotoxicity and transaminase measurement during isoniazid chemoprophylaxis in children","volume":"14","author":"Palusci","year":"1985","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ccm.2009.08.012_bib130","first-page":"581","article-title":"Liver enzyme disturbances during isoniazid chemoprophylaxis in children","volume":"110","author":"Beaudry","year":"1974","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib131","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1164\/arrd.1978.118.4.794","article-title":"Isoniazid hepatotoxicity in children","volume":"118","author":"Rapp","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib132","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-3476(76)80949-3","article-title":"Isoniazid hepatitis in adolescents","volume":"89","author":"Litt","year":"1976","journal-title":"J Pediatr"},{"key":"10.1016\/j.ccm.2009.08.012_bib133","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1136\/adc.62.10.1005","article-title":"Reduced incidence of tuberculosis by prophylactic chemotherapy in subjects showing strong reactions to tuberculin testing","volume":"82","author":"Ormerod","year":"1987","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ccm.2009.08.012_bib134","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/adc.78.2.169","article-title":"Rifampicin and isoniazid prophylactic chemotherapy for tuberculosis","volume":"78","author":"Ormerod","year":"1998","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ccm.2009.08.012_bib135","first-page":"761","article-title":"Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood\u2013a pilot project","volume":"48","author":"Magdorf","year":"1994","journal-title":"Pneumologie"},{"key":"10.1016\/j.ccm.2009.08.012_bib136","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1086\/425610","article-title":"Use of intermittent rifampin and pyrazinamide therapy for latent tuberculosis infection in a targeted tuberculin testing program","volume":"39","author":"Priest","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib137","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3201\/eid1205.050681","article-title":"Isoniazid preventive therapy and risk for resistant tuberculosis","volume":"12","author":"Balcells","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib138","first-page":"501","article-title":"Isoniazid and rifampin-resistant tuberculosis in San Diego County, California, United States, 1993\u20132002","volume":"9","author":"LoBue","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib139","first-page":"19","article-title":"Treatment of latent tuberculosis in persons at risk for multidrug-resistant tuberculosis: systematic review","volume":"10","author":"Fraser","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/ajrccm.153.1.8542139","article-title":"Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis","volume":"153","author":"Kritski","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2009.08.012_bib141","first-page":"1149","article-title":"Primary drug-resistant tuberculosis in children","volume":"12","author":"Schaaf","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib142","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/08035250600675741","article-title":"Childhood drug-resistant tuberculosis in the Western Cape Province of South Africa","volume":"95","author":"Schaaf","year":"2006","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.ccm.2009.08.012_bib143","doi-asserted-by":"crossref","DOI":"10.2105\/AJPH.2008.143271","article-title":"Surveillance of antituberculosis drug resistance among children from the Western Cape Province of South Africa\u2013an upward trend","author":"Schaaf","year":"2009","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ccm.2009.08.012_bib144","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1128\/JCM.01291-06","article-title":"Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape Province of South Africa","volume":"44","author":"Marais","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"Pt 2","key":"10.1016\/j.ccm.2009.08.012_bib145","first-page":"995","article-title":"Drug-resistant tuberculosis in children","volume":"97","author":"Schaaf","year":"2007","journal-title":"S Afr Med J"},{"key":"10.1016\/j.ccm.2009.08.012_bib146","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1542\/peds.109.5.765","article-title":"Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up","volume":"109","author":"Schaaf","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.ccm.2009.08.012_bib147","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1183\/09031936.05.00047805","article-title":"Cost-effectiveness of isoniazid chemoprevention in close contacts","volume":"26","author":"Diel","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2009.08.012_bib148","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/00002030-199908200-00016","article-title":"Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective","volume":"13","author":"Bell","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2009.08.012_bib149","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/1099-1050(200007)9:5<411::AID-HEC524>3.0.CO;2-9","article-title":"The cost-effectiveness of evidence-based guidelines and practice for screening and prevention of tuberculosis","volume":"9","author":"Macintyre","year":"2000","journal-title":"Health Econ"},{"key":"10.1016\/j.ccm.2009.08.012_bib150","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0140-6736(00)02870-1","article-title":"Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial","volume":"356","author":"Fitzgerald","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2009.08.012_bib151","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1097\/00002030-200309260-00007","article-title":"Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?","volume":"17","author":"Churchyard","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2009.08.012_bib152","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(01)06712-5","article-title":"HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers","volume":"358","author":"Sonnenberg","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2009.08.012_bib153","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.inf.0000172933.22481.36","article-title":"Recurrent culture-confirmed tuberculosis in human immunodeficiency virus-infected children","volume":"24","author":"Schaaf","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ccm.2009.08.012_bib154","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study","volume":"359","author":"Badri","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2009.08.012_bib155","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1086\/338641","article-title":"Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy","volume":"34","author":"Santoro-Lopes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.012_bib156","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","article-title":"The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil","volume":"21","author":"Golub","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2009.08.012_bib157","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/QAD.0b013e328327964f","article-title":"Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort","volume":"23","author":"Golub","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2009.08.012_bib158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2431-8-1","article-title":"Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy","volume":"8","author":"Walters","year":"2008","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.ccm.2009.08.012_bib159","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"CHER Study Team. Early antiretroviral therapy and mortality among HIV-infected infants","volume":"359","author":"Violari","year":"2008","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1016\/j.ccm.2010.01.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000}}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523109000884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523109000884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T05:23:21Z","timestamp":1544851401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523109000884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":159,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0272523109000884"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2009.08.012","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}